HIGHLIGHTS
- who: Emanuel Wyler from the Institut of Pediatric Neurology, Berlin, Germany have published the research work: Key benefits of dexamethasone and antibody treatment in COVID-19 hamster models revealed by single-cell transcriptomics, in the Journal: (JOURNAL)
- what: The authors aimed at better understanding the effects of two standardof-care drugs dexamethasone and anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies on infection and host responses. To generalize the observation of this transcriptional dynamic, the authors applied diffusion map analysis of neutrophils to identify their most prominent direction of variation , which the . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.